ArriVent BioPharma, Inc.
AVBP
$20.82
-$0.35-1.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -14.53% | 5.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.17% | -5.70% | |||
| Operating Income | 2.17% | 5.70% | |||
| Income Before Tax | -0.34% | 5.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.34% | 5.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.34% | 5.99% | |||
| EBIT | 2.17% | 5.70% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.07% | 6.20% | |||
| Normalized Basic EPS | 0.05% | 6.22% | |||
| EPS Diluted | 0.07% | 6.20% | |||
| Normalized Diluted EPS | 0.05% | 6.22% | |||
| Average Basic Shares Outstanding | 0.40% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.40% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||